Significance of Self-Injectable Biologics in Japanese Patients with Severe Allergic Diseases: Focusing on Pen-Type Devices and Copayment.
Journal Information
Full Title: Patient Prefer Adherence
Abbreviation: Patient Prefer Adherence
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Medicine, General & Internal
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Disclosure Prof. Dr. Masato Muraki reports personal fees from GlaxoSmithKline K.K., AstraZeneca K.K., Sanofi K.K., Novartis Pharma K.K., Nippon Boehringer Ingelheim Co., Ltd., and Kyorin Pharmaceutical Co., Ltd., outside the submitted work. Prof. Dr. Hisako Matsumoto reports personal fees from AstraZeneca, Sanofi, GSK, and Novartis, outside the submitted work. Prof. Dr. Yuji Tohda reports consultant work for AstraZeneca, Kyorin, Sanofi, TeijinPhama, and Novartis, outside the submitted work. The authors report no other conflicts of interest related to this work."
"No funding was obtained for this study."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025